An Open Label Study to Evaluate the Impact of Novel Fixed-dose Testosterone/Dutasteride Combinations on the Relative Bioavailability of the Individual Dutasteride and Testosterone Components
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Dutasteride; Testosterone
- Indications Benign prostatic hyperplasia; Prostate cancer; Prostatic intraepithelial neoplasia
- Focus Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2009 Actual patient number (60) added as reported by ClinicalTrials.gov.
- 04 Sep 2007 Status changed from recruiting to completed.